ATS 2024 Final Program

Click on the session title to view the speakers

158

MONDAY • MAY 20

P351 Up in Smoke: Unraveling the Mystery of Cystic Lung Disease in Marijuana Enthusiasts P352 Birt-Hogg Dube (BHD), A Rare Autosomal Dominant Disorder With Pulmonary Complications

P364 Immune-Checkpoint Inhibitor-Related Eosinophilic Pneumonia P365 Ocrelizumab Induced Organizing Pneumonia: A Case Report P366 Multiplying Cellular Injury, Drug-induced Pneumonitis From Mirvetuximab Soravtansine P367 On the Rise: Keep an Eye Out for Pembrolizumab Induced Lung Toxicity P368 Organizing Fibrinopurulent Pleuritis in a Patient on Ibrutinib for Chronic Lymphocytic Leukemia P369 Dupilumab-Induced Hyper-Eosinophilia: A Call for Treatment Guideline B55 EXPLORING LUNG HEALTH ACROSS POPULATIONS 9:15 a.m. - 4:15 p.m. San Diego Convention Center Area C (Hall A-B2, Ground Level) Viewing: Posters will be on display for entire session Discussion: 11:30-12:30 Discussionwith facilitators, authors, andattendees 12:30-1:15 Authorswill beby their posters for individual discussionwithattendees P224 Mortality From Non-Malignant Respiratory Diseases Among Dentists in the United States During 1979-2018 P225 Variation in Race/Ethnicity-specific COVID-19 Vaccine Uptake by Occupation P226 The Association Between Employment in Coal Mining and History of Injury, Chronic Pain, and Prescription Opioid Use P227 Association Between Chronic Respiratory Symptoms and Pulmonary Function Following Deployment to Afghanistan and Iraq Among United States Veterans P228 The Digital Health Landscape in a Scottish National Pulmonary Hypertension Population P229 Obstructive Sleep Apnea, Excessive Daytime Sleepiness, and Its Association With Road Traffic Accidents Among Nigerian Truck Drivers BEHAVIORAL • CLINICAL THEMATIC POSTER SESSION

CLINICAL THEMATIC POSTER SESSION

B54 CASE REPORTS IN ONCOLOGIC TREATMENT-RELATED LUNG DISEASE 9:15 a.m. - 4:15 p.m. Viewing: Posters will be on display for entire session Discussion: 11:30-12:30 Discussionwith facilitators, authors, andattendees 12:30-1:15 Authorswill beby their posters for individual discussionwithattendees P354 Folfox Chemotherapy Induced Lung Fibrosis and Bilateral Pneumothoraxes P355 A Case of Pomalidomide Induced Acute Eosinophilic Pneumonia P356 An Original Occurrence of Organizing Pneumonia From Obinutuzumab P357 Y-90 Radioembolization Induced Pulmonary Toxicity P358 A Case of Drug-Induced Pneumonitis From Trastuzumab-Deruxtecan for Metastatic Breast Cancer Refractory to High-Dose Steroids and Intravenous Immunoglobulin P359 Durvalumab Induced Pneumonitis: A Case Report P360 Rapidly Progressive Pneumonitis Days After Receiving Tivdak: A New Antibody-Drug Conjugate P361 FOLFOX Induced Interstitial Lung Disease P362 A Patient With Metastatic Uterine Carcinosarcoma With Presumed Pneumonitis Secondary to Investigational Drug Db-1303, an Antibody-Drug Conjugate Comprised of Anti-HER2 Monoclonal Antibody Linked to a DNA Topoisomerase I Inhibitor P363 A Cavitary Lung Lesion Secondary to Idiopathic Hypereosinophilic Syndrome Treated With Mepolizumab: A Case Report San Diego Convention Center Area D (Hall A-B2, Ground Level)

ATS 2024 Conference Program • San Diego, CA